Ingredient Safety

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

ACI and CHPA praise FDA for announcing the withdrawal of its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.

This week CHPA filed an amicus brief urging the 9th Circuit U.S. Court of Appeals to confirm an appellate panel’s holding that a class in a class action lawsuit cannot be certified with more than a de minimis number of uninjured class members.

CHPA this week filed an amicus brief urging the 9th Circuit US Court of Appeals to confirm an appellate panel’s holding that a class in a class action lawsuit cannot be certified with more than a de minimis number of uninjured class members.

The dietary supplements segment has just experienced its largest annual growth rate since 1997. Hear from Dr. Pieter Cohen as he shares his insights on how modernization of DSHEA will help improve category compliance and credibility.

In a new letter, ACI and CHPA call on FDA to withdraw its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.

CHPA released the following statement in response to FDA’s warning that consumers avoid certain male enhancement and weight loss products sold by major online retailers due to hidden, potentially dangerous drug ingredients.